FDA.reportPublic FDA data

Yesintek 45 MG per 0.5 ML Injection

RxCUI
2705603
RxNorm name
Yesintek 45 MG per 0.5 ML Injection
Display name
Yesintek 45 MG per 0.5 ML Injection
Full name
Yesintek 45 MG per 0.5 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:48

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761406Yesintekustekinumab-kfce351(k) InterchangeableRx2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
12a75613-ee33-d30a-215b-2a51cfa19b00Yesintek 45 MG in 0.5 ML Injection [PSN] · 0.5 ML ustekinumab-kfce 90 MG/ML Injection [Yesintek] [SBD] · 0.5 ML Yesintek 90 MG/ML Injection [SY] · Yesintek 45 MG per 0.5 ML Injection [SY]49These highlights do not include all the information needed to use YESINTEK safely and effectively. See full prescribing information for YESINTEK. YESINTEK TM (ustekinumab-kfce) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2024 YESINTEK TM (ustekinumab-kfce) is biosimilar* to STELARA ® (ustekinumab).20251209